Zacks: Analysts Anticipate Merit Medical Systems, Inc. (NASDAQ:MMSI) Will Post Earnings of $0.50 Per Share

Analysts forecast that Merit Medical Systems, Inc. (NASDAQ:MMSI) will announce $0.50 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Four analysts have made estimates for Merit Medical Systems’ earnings. The lowest EPS estimate is $0.44 and the highest is $0.54. Merit Medical Systems posted earnings of $0.54 per share in the same quarter last year, which suggests a negative year-over-year growth rate of 7.4%. The company is expected to issue its next earnings report on Wednesday, February 23rd.

On average, analysts expect that Merit Medical Systems will report full-year earnings of $2.16 per share for the current fiscal year, with EPS estimates ranging from $2.11 to $2.20. For the next fiscal year, analysts expect that the company will post earnings of $2.40 per share, with EPS estimates ranging from $2.35 to $2.43. Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that that provide coverage for Merit Medical Systems.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Thursday, October 28th. The medical instruments supplier reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.44 by $0.08. Merit Medical Systems had a return on equity of 12.81% and a net margin of 4.10%. The business had revenue of $267.02 million during the quarter, compared to analysts’ expectations of $260.61 million. During the same period in the previous year, the firm earned $0.42 earnings per share. The firm’s quarterly revenue was up 9.4% compared to the same quarter last year.

MMSI has been the topic of a number of research reports. Wells Fargo & Company boosted their price target on Merit Medical Systems from $68.00 to $74.00 and gave the company an “equal weight” rating in a report on Friday, October 29th. Barrington Research initiated coverage on Merit Medical Systems in a report on Thursday, September 30th. They set a “buy” rating and a $79.00 target price on the stock. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $76.50.

MMSI stock opened at $57.81 on Friday. The business’s 50-day moving average price is $64.10 and its two-hundred day moving average price is $66.88. The company has a current ratio of 2.17, a quick ratio of 1.20 and a debt-to-equity ratio of 0.27. The firm has a market cap of $3.26 billion, a PE ratio of 76.07, a P/E/G ratio of 2.21 and a beta of 1.11. Merit Medical Systems has a 1-year low of $52.43 and a 1-year high of $73.85.

Several institutional investors and hedge funds have recently modified their holdings of MMSI. First Horizon Advisors Inc. lifted its position in Merit Medical Systems by 23.4% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,032 shares of the medical instruments supplier’s stock valued at $90,000 after acquiring an additional 196 shares in the last quarter. Louisiana State Employees Retirement System grew its stake in Merit Medical Systems by 0.8% in the 4th quarter. Louisiana State Employees Retirement System now owns 24,600 shares of the medical instruments supplier’s stock valued at $1,533,000 after buying an additional 200 shares in the last quarter. Dark Forest Capital Management LP purchased a new position in shares of Merit Medical Systems during the 2nd quarter valued at $26,000. Point72 Hong Kong Ltd purchased a new position in shares of Merit Medical Systems during the 3rd quarter valued at $31,000. Finally, Maverick Capital Ltd. grew its position in shares of Merit Medical Systems by 1.6% during the 2nd quarter. Maverick Capital Ltd. now owns 29,368 shares of the medical instruments supplier’s stock valued at $1,899,000 after purchasing an additional 474 shares in the last quarter. Institutional investors own 94.04% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups.

Featured Article: Oversold

Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.